Parker Hannifin
PH
952.79
-32.12
-3.26%
Parker Hannifin
US · PH
#171 by market cap
Listed 1970
952.79
-32.12
-3.26%
Live - 5344 symbols - heartbeat 23s ago
· 2026-10-08 07:40
Pre-market
948.95
-0.40%
After-hours
952.79
0.00%
Overnight
953.00
+0.02%
- Market cap
- 120.16B
- P/E (TTM)i
- 33.45
- P/Bi
- 7.80
- EPSi
- 28.48
- Div yieldi
- 0.78%
- 52W posi
- 63%
Reader sentiment
Are you bullish or bearish on PH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.03, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +8.31% YoY
Margins
- Gross margin
- 37.69%
- Operating margin
- 21.55%
- Net margin
- 16.97%
Key ratios & quality
- Enterprise valuei
- 128.18B
- PEG ratioi
- 1.63
- Altman Z-Scorei
- 7.03
PEG uses trailing P/E against the 3-year net income growth rate (20.54%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.32B | 13.70B | 14.35B | 15.86B | 19.07B | 19.93B | 19.85B | 21.50B |
| Gross profit | 3.63B | 3.40B | 4.74B | 5.31B | 6.43B | 7.13B | 7.32B | 8.10B |
| Selling & admin expenses | 1.54B | 1.66B | 2.38B | 2.50B | 3.35B | 3.32B | 3.26B | 3.47B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.09B | 1.75B | 2.36B | 2.81B | 3.08B | 3.81B | 4.05B | 4.63B |
| Pretax profit | 1.95B | 1.51B | 2.25B | 1.61B | 2.68B | 3.60B | 4.11B | 4.56B |
| Tax | 424.39M | 304.52M | 500.10M | 298.04M | 596.00M | 750.00M | 575.00M | 914.00M |
| Net profit | 1.53B | 1.20B | 1.75B | 1.32B | 2.08B | 2.85B | 3.53B | 3.65B |
| Basic EPS | 12 | 9 | 14 | 10 | 16 | 22 | 28 | 29 |
| Diluted EPS | 11.57 | 9.26 | 13.35 | 10.09 | 16.04 | 21.84 | 27.12 | 28.48 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 4.96B | 5.24B | 5.08B | 5.17B | 5.49B | 5.76B |
| Gross profit | 1.83B | 1.96B | 1.91B | 1.93B | 2.02B | 2.25B |
| Selling & admin expenses | 793.00M | 839.00M | 873.00M | 837.00M | 884.00M | 874.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.04B | 1.12B | 1.03B | 1.09B | 1.13B | 1.37B |
| Pretax profit | 995.00M | 1.07B | 1.04B | 1.06B | 1.12B | 1.34B |
| Tax | 33.00M | 148.00M | 232.00M | 219.00M | 215.00M | 248.00M |
| Net profit | 962.00M | 923.00M | 808.00M | 845.00M | 904.00M | 1.09B |
| Basic EPS | 7 | 7 | 6 | 7 | 7 | 9 |
| Diluted EPS | 7.37 | 7.15 | 6.29 | 6.60 | 7.06 | 8.54 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 7.67B | 5.03B | 5.62B | 12.05B | 6.83B | 6.80B | 6.95B | 7.70B |
| Cash & ST investments | 3.37B | 756.32M | 772.23M | 563.66M | 475.18M | 422.00M | 467.00M | 501.00M |
| Inventory | 1.68B | 1.96B | 2.09B | 2.21B | 2.91B | 2.79B | 2.84B | 3.17B |
| Total assets | 17.58B | 19.89B | 20.34B | 25.94B | 29.96B | 29.30B | 29.49B | 30.88B |
| Total current liabilities | 3.15B | 3.15B | 3.10B | 5.86B | 7.74B | 7.31B | 5.82B | 6.10B |
| Short-term debt | 587.01M | 809.53M | 2.82M | 1.72B | 3.76B | 3.40B | 1.79B | 1.75B |
| Long-term debt | 6.52B | 7.65B | 6.58B | 9.76B | 8.80B | 7.16B | 7.49B | 6.77B |
| Total liabilities | 11,608,538,000.00 | 13,645,983,000.00 | 11,927,530,000.00 | 17,084,023,000.00 | 19,626,193,000.00 | 17,217,000,000.00 | 15,803,000,000.00 | 15,464,000,000.00 |
| Total equity | 5.97B | 6.24B | 8.41B | 8.86B | 10.34B | 12.08B | 13.69B | 15.41B |
| Retained earnings | 12.78B | 13.64B | 14.92B | 15.66B | 17.04B | 19.11B | 21.78B | 24.49B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 6.78B | 6.95B | 7.23B | 7.19B | 7.61B | 7.70B |
| Cash & ST investments | 408.74M | 467.00M | 473.00M | 427.00M | 476.00M | 501.00M |
| Inventory | 2.82B | 2.84B | 3.08B | 3.15B | 3.18B | 3.17B |
| Total assets | 28.92B | 29.49B | 30.68B | 30.51B | 30.68B | 30.88B |
| Total current liabilities | 5.61B | 5.82B | 6.78B | 6.09B | 6.74B | 6.10B |
| Short-term debt | 1.95B | 1.79B | 2.85B | 2.39B | 2.81B | 1.75B |
| Long-term debt | 7.42B | 7.49B | 7.49B | 7.48B | 6.77B | 6.77B |
| Total liabilities | 15,517,983,000.00 | 15,803,000,000.00 | 16,891,000,000.00 | 16,191,000,000.00 | 16,062,000,000.00 | 15,464,000,000.00 |
| Total equity | 13.40B | 13.69B | 13.79B | 14.32B | 14.62B | 15.41B |
| Retained earnings | 21.08B | 21.78B | 22.36B | 22.97B | 23.65B | 24.49B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.73B | 2.07B | 2.58B | 2.44B | 2.98B | 3.38B | 3.78B | 4.36B |
| Depreciation & amortization | 436.19M | 537.53M | 595.39M | 571.76M | 818.00M | 927.00M | 907.00M | 937.00M |
| Free cash flow | 1.54B | 1.84B | 2.37B | 2.21B | 2.60B | 2.98B | 3.34B | 3.91B |
| Dividends paid | -412.47M | -453.84M | -475.17M | -569.86M | -704.00M | -782.00M | -861.00M | -936.00M |
| Stock buybacks / issuance | -860.05M | -216.05M | -218.82M | -460.06M | -297.00M | -332.00M | -1.77B | -1.26B |
| Ending cash balance | 3.22B | 685.51M | 733.12M | 6.65B | 475.00M | 422.00M | 467.00M | 501.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 630.00M | 1.47B | 782.00M | 862.00M | 984.00M | 1.74B |
| Depreciation & amortization | 222.00M | 230.00M | 232.00M | 233.00M | 235.00M | 237.00M |
| Free cash flow | 542.00M | 1.34B | 693.00M | 768.00M | 881.00M | 1.56B |
| Dividends paid | -210.00M | -231.00M | -228.00M | -228.00M | -227.00M | -253.00M |
| Stock buybacks / issuance | -668.00M | -906.00M | -522.00M | -145.00M | -340.00M | -255.00M |
| Ending cash balance | 409.00M | 467.00M | 473.00M | 427.00M | 476.00M | 501.00M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 25.59 | 19.98 | 24.06 | 15.26 | 21.73 | 25.40 | 27.42 | 25.08 |
| ROA %i | 9.19 | 6.47 | 8.71 | 5.68 | 7.45 | 9.60 | 12.01 | 12.09 |
| ROIC %i | 13.91 | 10.33 | 13.09 | 8.63 | 11.54 | 14.21 | 16.99 | 16.88 |
| 5-year avg ROE %i | 19.75 | 20.25 | 21.69 | 20.74 | 21.27 | 21.20 | 22.74 | 22.98 |
| EBIT margin %i | 14.83 | 13.29 | 17.40 | 11.79 | 17.07 | 20.58 | 22.75 | 23.09 |
| FCF / sales %i | 10.72 | 13.42 | 16.48 | 13.94 | 13.63 | 14.97 | 16.83 | 18.16 |
| Current ratioi | 2.43 | 1.60 | 1.81 | 2.06 | 0.88 | 0.93 | 1.19 | 1.26 |
| Quick ratioi | 1.84 | 0.91 | 1.06 | 0.59 | 0.47 | 0.49 | 0.63 | 0.65 |
| Debt / assetsi | 40.44 | 42.55 | 32.37 | 44.25 | 41.91 | 36.04 | 31.48 | 27.59 |
| LT debt / equityi | 109.37 | 122.88 | 78.37 | 110.26 | 85.18 | 59.29 | 54.77 | 43.92 |
| Interest coveragei | 11.17 | 5.91 | 9.99 | 7.32 | 5.67 | 8.10 | 11.04 | 12.38 |
| Revenue CAGR (3Y) %i | 8.02 | 4.42 | 0.11 | 3.47 | 11.66 | 11.58 | 7.76 | 4.09 |
| Net income CAGR (3Y) %i | 23.63 | 6.92 | 18.07 | -4.79 | 20.12 | 17.66 | 38.97 | 20.54 |
| FCF CAGR (3Y) %i | 13.09 | 18.79 | 20.58 | 12.95 | 12.23 | 8.06 | 14.74 | 14.54 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 27.16 | 27.42 | 27.31 | 25.79 | 24.86 | 25.08 |
| ROA %i | 11.60 | 12.01 | 12.08 | 12.03 | 11.68 | 12.09 |
| ROIC %i | 16.37 | 16.99 | 16.82 | 16.69 | 16.18 | 16.88 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 22.49 | 22.75 | 23.31 | 22.34 | 22.39 | 23.09 |
| FCF / sales %i | 15.79 | 16.83 | 16.90 | 16.32 | 17.53 | 18.16 |
| Current ratioi | 1.21 | 1.19 | 1.07 | 1.18 | 1.13 | 1.26 |
| Quick ratioi | 0.63 | 0.63 | 0.54 | 0.57 | 0.59 | 0.65 |
| Debt / assetsi | 32.41 | 31.48 | 33.68 | 32.35 | 31.23 | 27.59 |
| LT debt / equityi | 55.42 | 54.77 | 54.33 | 52.30 | 46.33 | 43.92 |
| Interest coveragei | 10.37 | 11.04 | 11.76 | 11.37 | 11.60 | 12.38 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Diversified Industrial is the largest reported line at 67.16% of revenue, across 2 reported segments.
- Aerospace Systems follows at 32.84%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Diversified Industrial67.16%
Aerospace Systems32.84%
Region
United States64.28%
Other countries35.72%
Quote time 2026-10-08 07:40:26 · For reference only, not investment advice and not tailored to your situation.